Enabling altruism: Evaluating the adult living liver donor
Robert A. Fisher – 29 March 2007
Early posttransplantation portal vein stenosis following living donor liver transplantation: Percutaneous transhepatic primary stent placement
Gi‐Young Ko, Kyu‐Bo Sung, Hyun‐Ki Yoon, SungGyu Lee – 29 March 2007 – Surgical treatments have usually been preferred for early posttransplantation portal inflow abnormalities. However, these treatments are limited due to their technical difficulty and multiple complicating factors. The present study reports the efficacy and safety of percutaneous transhepatic primary stent placement to treat early posttransplantation (≤1 month) portal vein (PV) stenosis. A total of 9 patients who had undergone living donor liver transplantation underwent percutaneous stent placement to treat PV stenosis.
Noninvasive tests in the post–liver transplantation setting
Evangelos Cholongitas, Marco Senzolo, Alberto Quaglia, David Patch, Amar P. Dhillon, Andrew K. Burroughs – 29 March 2007
Tissue factor‐dependent procoagulant activity of isolated human hepatocytes: Relevance to liver cell transplantation
Xavier Stéphenne, Olivier Vosters, Mustapha Najimi, Claire Beuneu, Dung Khuu Ngoc, Walter Wijns, Michel Goldman, Etienne M. Sokal – 29 March 2007 – Liver cell transplantation (LCT) aims to correct inborn liver function defects by infusing metabolically active cells into the diseased liver. Further improvement in LCT might depend on the prevention of early loss of transplanted cells.
Erratum
29 March 2007
Working up donors for high‐urgency and elective adult‐to‐adult live donor liver transplantation
See Ching Chan, Sheung Tat Fan, Chi Leung Liu, Chung Mau Lo, Banny K. Lam, Evelyn W. Lee – 29 March 2007 – Donor workup for adult‐to‐adult live donor liver transplantation is done to ensure that the donor remains physically and psychologically healthy after saving or improving the life of the recipient. Even though two‐thirds of the liver transplants in our center were from live donors, this life‐saving procedure remains a mere treatment option, given the magnitude of the donor operation with the associated donor risks.
Anesthesia care for adult live donor hepatectomy: Our experiences with 100 cases
Ashwani Chhibber, Jason Dziak, Jefferey Kolano, J. Russell Norton, Stewart Lustik – 29 March 2007 – A total of 100 patients who underwent elective lobar donor hepatectomy from 2000 to 2002 at the University of Rochester Medical Center were reviewed.
Recipient and donor factors influence the incidence of graft‐vs.‐host disease in liver transplant patients
Edie Y. Chan, Anne M. Larson, Terry B. Gernsheimer, Kris V. Kowdley, Robert L. Carithers, Jorge D. Reyes, James D. Perkins – 29 March 2007 – Acute cellular graft‐vs.‐host disease (GVHD) following liver transplantation has an incidence of 1 to 2% and a mortality rate of 85%. Our aim was to identify a patient population at high risk for developing GVHD using a large clinical database to study both recipient and donor factors. We compared our liver transplant patients who developed GVHD to those that did not for recipient and donor factors and combinations of factors.
Combined HLA‐DR and ‐DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis
Evangelos Cholongitas, George V. Papatheodoridis, Paola Zappoli, Athanasios Giannakopoulos, David Patch, Laura Marelli, Vibhakorn Shusang, George Kalambokis, Graham Shirling, Nancy Rolando, A. K. Burroughs – 29 March 2007 – Combined disparity of human leukocyte antigen (HLA)‐DR and ‐DQ between mother and fetus is associated with less severe ulcerative colitis (UC) during pregnancy. We evaluated whether donor‐recipient HLA disparity after liver transplantation (LT) affects UC in patients with primary sclerosing cholangitis (PSC).